Dookhan has been accused of
faking drug results, forging signatures and mixing samples at a state police lab.
Not exact matches
According to Living Goods, clients may also be reluctant to buy
drugs from other private providers because of the risk of getting a counterfeit medicine.63 Living Goods sent us a study conducted at the midline of its RCT that claims that both availability of counterfeit
drugs and
drug prices decreased at private retailers in areas where CHPs worked.64 According to the study, about 37 % of private
drug shops in the areas it studied sold
fake ACT
drugs, 65 and availabilty of
fake ACTs was about 50 % lower among non-Living Goods sellers in the areas where Living Goods worked.66 Additional
results on these potential effects will be made available when the full RCT is published.
The
resulting bits of quasi-proclamation and pseudo-communication are both sinister and amusing by turns, calling to mind the gentle snark of Ed Ruscha's late - 1970s word pastels: «
drug allergy
fake» loiters just far enough from «radical wonton» to establish plausible deniability.
In the media recently was a revealling story on «dubious» practices in research, describing how the well - known science publisher Elsevier had published a series of «
fake» journals that were dedicated entirely to publishing
results from
drug company research (such as the «Australasian Journal of Bone and Joint Medicine `, dedicated to
«Little Annie» Dookhan is accused of
faking test
results, intentionally contaminating and padding suspected
drug samples, forging co-workers» signatures on lab reports, and falsely claiming to have a master's degree in chemistry.